Clinical Trial Update: Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML. [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of CD4CAR CAR-T therapy as a second-line treatment for chronic myelomonocytic leukemia (CMML), currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Drugs mentioned

• CD4CAR

Snippet

Sponsor: Huda Salman | Conditions: Chronic Myelomonocytic Leukemia | Phase 1 | Status: RECRUITING